enoxaparin becat 60mg/0.6ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
enoxaparin becat 80mg/0.8ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
enoxaparin becat 100mg/1ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 100mg/1ml
enoxaparin ledraxen
pharmalogic ltd - enoxaparin sodium - solution for injection - enoxaparin sodium 100 mg / 1 ml - enoxaparin - enoxaparin is indicated in adults for:• prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), excluding pe likely to require thrombolytic therapy or surgery. • prevention of thrombus formation in extra corporeal circulation during haemodialysis. • acute coronary syndrome: - treatment of unstable angina and non st-segment elevation myocardial infarction (nstemi), in combination with oral acetylsalicylic acid. - treatment of acute st-segment elevation myocardial infarction (stemi) including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).
heparin sodium 1,000 i.u./ml solution for injection or concentrate for solution for infusion, 5ml ampoules
wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin
heparin sodium 1,000 i.u./ml solution for injection or concentrate for solution for infusion, 10ml ampoules
wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin
heparin sodium (pfizer)
pfizer new zealand limited - heparin sodium 5000 iu/ml; - solution for injection - 25000 iu/5ml - active: heparin sodium 5000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection
heparin sodium (pfizer)
pfizer new zealand limited - heparin sodium 1000 iu/ml; - solution for injection - 5000 iu/5ml - active: heparin sodium 1000 iu/ml excipient: hydrochloric acid sodium hydroxide water for injection
arixtra 7.5 mg0.6 ml
padagis israel agencies ltd, israel - fondaparinux sodium - solution for injection - fondaparinux sodium 12.5 mg/ml - fondaparinux - fondaparinux - treatment of adults with acute deep vein thrombosis (dvt) and treatment of acute pulmonary embolism (pe), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.
heparin sodium 1,000 i.u./ml solution for injection or concentrate for solution for infusion, 5ml vials
wockhardt uk limited - heparin sodium - solution injection or concentrate for solution infusion - 1000 international unit(s)/millilitre - heparin group; heparin